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Rare disease
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Summary
A case report of a 28-year-old patient, who presented with symptoms and signs of congestive heart failure and had clinical signs of
ventricular septal defect as well. On further work-up echocardiogram showed non-compaction of the left ventricle with severe left
ventricular systolic dysfunction and a ventricular septal defect. He was treated with standard treatment of heart failure and is doing well.
BACKGROUND
Left ventricular non-compaction (LVNC) also called
hypertrabeculation syndrome or spongy myocardium is a
rare disorder. It is classiﬁed as a primary genetic cardiomy-
opathy by the American Heart Association (AHA).1
Isolated LVNC can be either sporadic or familial and very
rarely can occur as a transient phenomenon during myo-
carditis. The prevalence of LVNC in the general popula-
tion is not known but a review from Switzerland
identiﬁed 34 cases within 15 years, which represented
0.014% of echocardiographic studies done over a 15-year
period.2 This may be an underestimate, since improved
echocardiographic image quality and increasing awareness
of this rare disorder will likely lead to enhanced recogni-
tion. Non-compacted myocardium is occasionally found
accompanying other congenital cardiac anomalies such as
ventricular septal defect (VSD).
Our case report is a very rare clinical entity that will
enhance awareness about its echocardiographic recognition.
CASE PRESENTATION
A 28-year-old man with no known comorbids presented
in clinic with complaints of breathlessness, swelling of
feet and palpitations for 6 months. He had exertional
breathlessness which had progressed and he was getting
short of breath on just walking for approximately 5 min.
He had paroxysmal nocturnal dyspnoea for 4 months and
orthopnoea for last 2 weeks. He complained of occasional
palpitations which had become more frequent for 1 week.
He denied chest pain, fever or ﬂu-like symptoms and had
no history of heart problems. His family history was
negative for premature coronary artery disease, heart
failure, hypertension, diabetes mellitus and sudden cardiac
death (SCD).
On examination, he was a young man lying comfort-
ably in bed with a pulse of 110 beats/min regular, blood
pressure of 125/80 mm Hg, raised jugular venous pressure
and pitting pedal oedema. Apex beat was palpable in
sixth intercostal space in anterior axillary line with no
thrills or parasternal heave. A pansystolic murmur was
audible at lower-left sternal edge. Bilateral crackles were
audible at the lung bases but no cyanosis or clubbing was
present. Clinical impression of decompensated heart
failure and VSD was made. Treatment was started with
diuretics, low-dose carvedilol and candesartan.
INVESTIGATIONS
Echocardiogram showed spongiform cardiomyopathy
with severe LV systolic dysfunction (LV ejection fraction,
LVEF approximately 20%) and global hypokinesia. A small
perimembranous VSD was seen measuring 5 mm with
left to right shunt, a peak gradient of 60 mm Hg and
QP : QS ratio of 1.3 (restrictive VSD). Right ventricular
systolic function was normal. There was grade III LV dia-
stolic dysfunction and a retracted posterior mitral valve
leaﬂet with moderate eccentric mitral regurgitation.
Holter monitor done for palpitations showed sinus tachy-
cardia correlating with time of symptoms recorded in
patient’s diary. The rest of baseline reports were normal.
OUTCOME AND FOLLOW-UP
The patient was seen in the clinic for follow-up.
Spironolactone and aspirin were added, doses of carvedilol,
furosemide and candesartan were optimised and the
patient was counselled regarding need for an implantable
cardiac deﬁbrillator (ICD) for primary prevention of SCD.
Six months following diagnosis, the patient has remained
stable on medical treatment.
DISCUSSION
LVNC is a rare cardiac disorder, classiﬁed as a primary
genetic cardiomyopathy by the AHA.1 The European
Society of Cardiology classiﬁed LVNC as an unclassiﬁed
cardiomyopathy.3 LVNC is characterised by an altered
ventricular myocardium containing trabeculae and deep
intertrabecular recesses resulting in thickened myocardium
with two layers consisting of non-compacted and com-
pacted myocardium. Also having direct communication
between the LV cavity and the deep intratrabecular
recesses, which are ﬁlled with blood from the LV cavity
without connection to the epicardial coronary arteries
(ﬁgure 1). Non-compacted myocardium is occasionally
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found accompanying other congenital cardiac disorders,
like bicuspid aortic valve, aorta-to-LV tunnel, Ebstein’s
anomaly, congenitally corrected transposition, hypoplastic
left heart syndrome and isomerism of the left atrial
appendage.4 Non-compacted myocardium has also been
seen in patients with atrial and VSDs as was the case in
our patient, patent ductus arteriosus5 and in cardiomyop-
athies due to neuromuscular disorders. LVNC can occur in
genetic syndromes and metabolic diseases including
Charcot-Marie-Tooth disease 1A, Barth syndrome and
Melnick-Needles syndrome, as well as nail-patella syn-
drome. It has been postulated that LVNC may be due to
intrauterine arrest of compaction of the loose interwoven
meshwork or pronounced hypertrabeculation may be due
to altered regulation in cell proliferation, differentiation
and maturation during LV wall formation.6 The preva-
lence of LVNC in the general population is not known
but has been described among patients undergoing echo-
cardiographic studies. A review from Switzerland identi-
ﬁed 34 cases within 15 years, which represented 0.014%
of echocardiograms that were performed.7 This may be an
underestimation, since improved echocardiographic image
quality and increasing awareness of LVNC will perhaps
lead to enhanced recognition of LVNC. LVNC can be
either sporadic or familial. In various reports, 12–50% of
patients with LVNC had a family history positive of this
condition.7 Mutations have been identiﬁed in at least nine
genes in LVNC patients including genes encoding LIM
domain-binding protein 3 (LDB3), α-dystrobrenin (DTNA),
tafazzin (TAZ), lamin A/C (LMNA), β-myosin heavy
chain (MYH7), α-cardiac actin (ACTC), cardiac troponin T
(TNNT2), SCN5A and tropomyosin 1 (TPM1).8 9 The
main clinical presentations of LVNC are congestive cardiac
failure, atrial and ventricular arrhythmias and thrombo-
embolic events including stroke.7 The ECG is usually
abnormal but there are no characteristic changes.7 ECG
abnormalities that can be seen include right or left bundle
branch block, fascicular block, atrial ﬁbrillation (AF) and
ventricular tachycardia.
The diagnosis of LVNC is usually established by echo-
cardiography. Cardiovascular MRI, cardiac CT and left
ventriculography are other imaging modalities that may
be diagnostic or raise the initial clinical suspicion.
Echocardiography has been utilised both to establish the
diagnosis and as an aid during patient follow-up.2 7
However, there is no universally accepted deﬁnition of
LVNC. Proposed echocardiographic criteria for LVNC are
based on observations from different centres. Jenni et al
proposed the criteria which included: (1) a thickened LV
wall consisting of two layers: a thin compacted epicar-
dial layer; and a markedly thickened endocardial layer
with numerous prominent trabeculations and deep
recesses with a maximum ratio of non-compacted to
compacted myocardium >2 : 1 at end-systole in the
parasternal short-axis view, (2) colour Doppler evidence
of ﬂow within the deep inter-trabecular recesses and (3)
prominent trabecular meshwork in the LV apex or mid-
ventricular segments of the inferior and lateral wall. All
three echocardiographic criteria are required for diagno-
sis and the criteria are assessed in the parasternal short-
axis views at base, mid- and apical levels.7 Other ﬁnd-
ings that can be seen on echocardiography include
reduced global LV systolic function, diastolic dysfunc-
tion, LV thrombi and abnormal papillary muscle struc-
ture (ﬁgures 2 and 3).7
The echocardiographic image of isolated LVNC can be
very heterogeneous including dilated forms, hyper-
trophic variant and restrictive types (ﬁgures 4 and 5).10
Published series have found that LVNC is linked with
high rates of morbidity and mortality in adults. In a
study of 34 patients (mean age 42) the probability of
survival free of death or heart transplantation at 5 years
was 58%.7
Figure 2 Echocardiographic image, left parasternal short-axis
view at papillary muscle level.
Figure 3 Echocardiographic image, left parasternal short-axis
view at midleft ventricular cavity level with colour Doppler.
Figure 1 Echocardiographic image, left parasternal short-axis
view at apical level.
2 of 4 BMJ Case Reports 2012; doi:10.1136/bcr-2012-006614
However, this study population represents a group of
severely affected patients with a poor prognosis but hope-
fully with the increasing awareness of LVNC, more subtle
forms in minimally symptomatic patients or severe forms
in asymptomatic patients will be detected, which may
change the prognosis. Clinical data on treatment of LVNC
are limited, and there is no speciﬁc therapy for LVNC.
Medical management depends on clinical manifestations,
LVEF, the presence or absence of arrhythmias and per-
ceived risk of thromboembolism. LVNC patients with
reduced LVEF, heart failure and asymptomatic systolic dys-
function are treated according to standard guidelines.
LVNC patients with or without AF are at high risk for
thromboembolism. In addition, given the high thrombo-
embolic risk, chronic anticoagulation therapy is recom-
mended in patients with LVNC and AF who do not
otherwise have an indication for anticoagulation.
Anticoagulation is also recommended in patients with
LVNC without AF with LVEF <40%. LVNC patients
should be advised to refrain from competitive endurance
sports or weight lifting. LVNC patients should receive
ICD therapy according to standard indications for ICD
therapy in patients with non-ischaemic cardiomyopathy.
Patients with LVNC who have end-stage heart failure are
candidates for cardiac transplantation evaluation.
Learning points
▸ Left ventricular non-compaction (LVNC) is a rare
sporadic or familial cardiomyopathy.
▸ The clinical presentations and prognosis of such
patients are variable; including heart failure, chest pain,
thromboembolic events and atrial and ventricular
arrhythmias.
▸ LVNC patients who have end-stage heart failure are
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Figure 5 Echocardiographic image with continuous wave
Doppler showing pressure gradient across the ventricular septal
defect.
Figure 4 Echocardiographic image, left parasternal long axis
view with colour Doppler showing ventricular septal defect.
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